Terfenadine Resensitizes Doxorubicin Activity in Drug-Resistant Ovarian Cancer Cells via an Inhibition of CaMKII/CREB1 Mediated ABCB1 Expression

Informatics https://pubmed.ncbi.nlm.nih.gov/36439493/ 2022-11-10T00:00:00Z Frontiers in Oncology